Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo

BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer related deaths in America. Monoclonal antibodies are a viable treatment option for inhibiting cancer growth. Tumor specific drug delivery could be achieved utilizing these monoclonal antibodies as targeting agents. This type of desi...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Jameel Ahmad, Kudgus, Rachel A., Szabolcs, Annamaria, Dutta, Shamit, Wang, Enfeng, Cao, Sheng, Curran, Geoffry L., Shah, Vijay, Curley, Steven, Mukhopadhyay, Debabrata, Robertson, J. David, Bhattacharya, Resham, Mukherjee, Priyabrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124468/
https://www.ncbi.nlm.nih.gov/pubmed/21738572
http://dx.doi.org/10.1371/journal.pone.0020347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124468/
https://www.ncbi.nlm.nih.gov/pubmed/21738572
http://dx.doi.org/10.1371/journal.pone.0020347

Ejemplares similares